Vly News - Professional news Platform

Diabetic retinopathy is the leading cause of vision loss and avoidable blindness in working-age Australians. It is now three years since the launch of KeepSight, Australia’s diabetes eye disease screening initiative that is turning attention to diabetes-related vision loss. In Part 2 of National Diabetes Week (10-16 July), Outlook check with some of the program’s key stakeholders. Black Taryn, Diabetes Australia – national program and policy director The daily burden of living with diabetes can be significant. It is estimated that people with diabetes face up to 180 diabetes-related decisions every day – that’s more than 65,000 extra decisions a year. Combined with busy personal and professional lives, remembering and scheduling regular eye exams can be ignored or put on a priority ‘list’. Add to that the global pandemic and significant disruption to routine health care over the past two years, and it’s no surprise that people’s regular eye exams may have fallen by the wayside

image: Utibe Essien, MD, MPH see again Credit: University of Pittsburgh PITTSBURGH, July 7, 2022 – While patients with diabetes on the Medicare Advantage plan are more likely to receive preventative care, they are less likely to be prescribed new, more expensive drugs and more likely to have high blood pressure and poorer blood glucose control than patients on the Cost plan Medicare-For-Services, according to a new study led by physician-scientists at the University of Pittsburgh School of Medicine. The study, published today in Diabetes Treatment, raised the red flag that – despite increasing access to preventative care – rapid growth in Medicare Advantage registrants could signal a trend toward poorer health outcomes and gaps in care when compared to their Medicare Fee-For-Service counterparts. “Preventive care is not enough to prevent patients from utilizing the healthcare system in the future,” said lead author Utibe Essien